Abstract
Purpose
To evaluate the safety of phacoemulsification cataract surgery in the patients undergoing dual antiplatelet therapy with aspirin and clopidogrel.
Methods
Consecutive patients undergoing phacoemulsification cataract surgery with a clear corneal incision under topical anesthesia were eligible for inclusion in the study. Thirty-eight eyes from 38 patients on combined aspirin and clopidogrel therapy who continued the treatment were classified into the maintenance group, a matched group of 38 eyes from 38 patients on no antiplatelet/anticoagulant therapy as the control group. The best-corrected visual acuity (BCVA) and incidences of complications were compared between the two groups.
Results
There was no significant difference in final BCVA between the maintenance group and the control group (p = 0.178). No significant difference existed in the incidences of hemorrhagic or non-hemorrhagic complications between the two groups (p = 0.529 and p = 0.589, respectively). Moreover, no surgery was postponed or cancelled due to hemorrhagic complications in either group, and no cardiovascular events occurred during the follow-up. There was no case of anterior chamber hemorrhage, vitreous hemorrhage, or suprachoroidal hemorrhage.
Conclusions
Our outcomes indicated that phacoemulsification cataract surgery using a clear corneal incision with topical anesthesia could be safely done without stopping dual antiplatelet therapy with aspirin and clopidogrel.
Similar content being viewed by others
References
Li C, Hirsh J, Xie C, Johnston MA, Eikelboom JW (2012) Reversal of the anti-platelet effects of aspirin and clopidogrel. J Thromb Haemost 10(4):521–528
Johnston SC, Easton JD, Farrant M, Barsan W, Conwit RA, Elm JJ, Kim AS, Lindblad AS, Palesch YY (2018) Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA. N Engl J Med 379:215–225
Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, Bax JJ, Borger MA, Brotons C, Chew DP, Gencer B, Hasenfuss G, Kjeldsen K, Lancellotti P, Landmesser U, Mehilli J, Mukherjee D, Storey RF, Windecker S (2016) 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent st-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 37(3):267–315
Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK (2001) Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345(7):494–502
Davies BR (2004) Combined aspirin and clopidogrel in cataract surgical patients: a new risk factor for ocular haemorrhage? Br J Ophthalmol 88(9):1226–1227
Kiire CA, Mukherjee R, Ruparelia N, Keeling D, Prendergast B, Norris JH (2014) Managing antiplatelet and anticoagulant drugs in patients undergoing elective ophthalmic surgery. Br J Ophthalmol 98(10):1320–1324
Moussouttas M (2005) Emerging therapies: clopidogrel and aspirin. Stroke 36(4):707
Albaladejo P, Samama CM (2010) Patients under anti-platelet therapy. Best Pract Res Clin Anaesthesiol 24(1):41–50
Hodge W, Horsley T, Albiani D, Baryla J, Belliveau M, Buhrmann R, O'Connor M, Blair J, Lowcock E (2007) The consequences of waiting for cataract surgery: a systematic review. CMAJ 176(9):1285–1290
Benzimra JD, Johnston RL, Jaycock P, Galloway PH, Lambert G, Chung AK, Eke T, Sparrow JM (2009) The cataract national dataset electronic multicentre audit of 55,567 operations: antiplatelet and anticoagulant medications. Eye (Lond) 23(1):10–16
Katz J, Feldman MA, Bass EB, Lubomski LH, Tielsch JM, Petty BG, Fleisher LA, Schein OD (2003) Risks and benefits of anticoagulant and antiplatelet medication use before cataract surgery. Ophthalmology 110(9):1784–1788
Wang Y, Wang Y, Zhao X, Liu L, Wang D, Wang C, Wang C, Li H, Meng X, Cui L, Jia J, Dong Q, Xu A, Zeng J, Li Y, Wang Z, Xia H, Johnston SC (2013) Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med 369(1):11–19
Johnston SC, Easton JD, Farrant M, Barsan W, Battenhouse H, Conwit R, Dillon C, Elm J, Lindblad A, Morgenstern L, Poisson SN, Palesch Y (2013) Platelet-oriented inhibition in new TIA and minor ischemic stroke (POINT) trial: rationale and design. Int J Stroke 8(6):479–483
Bowry AD, Brookhart MA, Choudhry NK (2008) Meta-analysis of the efficacy and safety of clopidogrel plus aspirin as compared to antiplatelet monotherapy for the prevention of vascular events. Am J Cardiol 101(7):960–966
Steinhubl SR, Berger PB, Mann JR, Fry ET, DeLago A, Wilmer C, Topol EJ (2002) Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 288(19):2411–2420
Pavlidis M, Korber N, Hohn F (2016) Surgical and functional results of 27-gauge vitrectomy combined with coaxial 1.8 mm microincision cataract surgery: a consecutive case series. Retina 36(11):2093–2100
Kim M, Park YS, Lee DH, Koh HJ, Lee SC, Kim SS (2015) Comparison of surgical outcome of 23-gauge and 25-gauge microincision vitrectomy surgery for management of idiopathic epiretinal membrane in pseudophakic eyes. Retina 35(10):2115–2120
Ong-Tone L, Paluck EC, Hart-Mitchell RD (2005) Perioperative use of warfarin and aspirin in cataract surgery by Canadian Society of cataract and refractive surgery members: survey. J Cataract Refract Surg 31(5):991–996
Barequet IS, Sachs D, Shenkman B, Priel A, Wasserzug Y, Budnik I, Moisseiev J, Salomon O (2011) Risk assessment of simple phacoemulsification in patients on combined anticoagulant and antiplatelet therapy. J Cataract Refract Surg 37(8):1434–1438
Kobayashi H (2010) Evaluation of the need to discontinue antiplatelet and anticoagulant medications before cataract surgery. J Cataract Refract Surg 36(7):1115–1119
Carter K, Miller KM (1998) Phacoemulsification and lens implantation in patients treated with aspirin or warfarin. J Cataract Refract Surg 24(10):1361–1364
Assia EI, Raskin T, Kaiserman I, Rotenstreich Y, Segev F (1998) Effect of aspirin intake on bleeding during cataract surgery. J Cataract Refract Surg 24(9):1243–1246
Kumar N, Jivan S, Thomas P, McLure H (2006) Sub-Tenon's anesthesia with aspirin, warfarin, and clopidogrel. J Cataract Refract Surg 32(6):1022–1025
Doganay O, Atalay B, Karadag E, Aga U, Tugrul M (2018) Bleeding frequency of patients taking ticagrelor, aspirin, clopidogrel, and dual antiplatelet therapy after tooth extraction and minor oral surgery. J Am Dent Assoc 149(2):132–138
Lu SY, Tsai CY, Lin LH, Lu SN (2016) Dental extraction without stopping single or dual antiplatelet therapy: results of a retrospective cohort study. Int J Oral Maxillofac Surg 45(10):1293–1298
Nathwani S, Martin K (2016) Exodontia in dual antiplatelet therapy: the evidence. Br Dent J 220(5):235–238
Sanchez-Palomino P, Sanchez-Cobo P, Rodriguez-Archilla A, Gonzalez-Jaranay M, Moreu G, Calvo-Guirado JL, Penarrocha-Diago M, Gomez-Moreno G (2015) Dental extraction in patients receiving dual antiplatelet therapy. Med Oral Patol Oral Cir Bucal 20(5):e616–e620
Li Q, Qian Y, Zhang Y, Sun G, Zhou X, Wang Z (2018) Continuation of aspirin therapy before cataract surgery with different incisions: safe or not? J Ophthalmol. https://doi.org/10.1155/2018/6543937
Olson RJ, Braga-Mele R, Chen SH, Miller KM, Pineda RN, Tweeten JP, Musch DC (2017) Cataract in the Adult Eye Preferred Practice Pattern®. Ophthalmology 124(2):P1–P119
Eagle KA, Guyton RA, Davidoff R, Edwards FH, Ewy GA, Gardner TJ, Hart JC, Herrmann HC, Hillis LD, Hutter AJ, Lytle BW, Marlow RA, Nugent WC, Orszulak TA (2004) ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to update the 1999 guidelines for coronary artery bypass graft surgery). Circulation 110(14):e340–e437
Brillat E, Rouberol F, Palombi K, Quesada JL, Bernheim D, Albaladejo P, Aptel F, Romanet JP, Chiquet C (2015) A case-control study to assess aspirin as a risk factor of bleeding in rhegmatogenous retinal detachment surgery. Graefes Arch Clin Exp Ophthalmol 253(11):1899–1905
Eisenberg MJ, Richard PR, Libersan D, Filion KB (2009) Safety of short-term discontinuation of antiplatelet therapy in patients with drug-eluting stents. Circulation 119(12):1634–1642
Park DW, Park SW, Park KH, Lee BK, Kim YH, Lee CW, Hong MK, Kim JJ, Park SJ (2006) Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up. Am J Cardiol 98(3):352–356
Burger W, Chemnitius JM, Kneissl GD, Rucker G (2005) Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation-review and meta-analysis. J INTERN MED 257(5):399–414
Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ramirez C, Sabate M, Jimenez-Quevedo P, Hernandez R, Moreno R, Escaned J, Alfonso F, Banuelos C, Costa MA, Bass TA, Macaya C (2006) Clopidogrel withdrawal is associated with proinflammatory and prothrombotic effects in patients with diabetes and coronary artery disease. Diabetes 55(3):780–784
Funding
This study was funded by grants from the National Natural Science Foundation of China (No. 81670868 and 81900879).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
No author has a financial or proprietary interest in any material or method mentioned.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the Institutional Review Board of Huashan Hospital affiliated to Fudan University and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Li, Q., Shen, X., Wang, S. et al. Combined aspirin and clopidogrel therapy in phacoemulsification cataract surgery: a risk factor for ocular hemorrhage?. Int Ophthalmol 40, 2023–2029 (2020). https://doi.org/10.1007/s10792-020-01378-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-020-01378-5